BiotechTube
Home/Blaze Bioscience/Jennifer K. Johnson, MS, JD
JK

Jennifer K. Johnson, MS, JD

SVP of Legal and Intellectual Property

Blaze Bioscience

Therapeutic Areas

Oncology

Blaze Bioscience Pipeline

DrugIndicationPhase
Tozuleristide (BLZ-100)Brain Cancer (Pediatric Glioma)Phase 2

Leadership Team at Blaze Bioscience

SD
Steven Daly, MS, MBA
President and CEO
ML
Mila Lobanova, MBA, CPA
EVP of Finance and Operations
KH
Kristi Harrington, MD, PhD
SVP of Clinical
JO
James Olson, MD, PhD
Scientific Founder and Key Advisor
View full Blaze Bioscience profile